Rein Therapeutics to present at September investor conferences
Rein Therapeutics (RNTX) said Brian Windsor, President and CEO, will present at upcoming September investor conferences.
AUSTIN, Texas, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") NASDAQ:RNTX, a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, President and Chief Executive Officer of Rei…